332 related articles for article (PubMed ID: 38794337)
21. Flavosomes, novel deformable liposomes for the co-delivery of anti-inflammatory compounds to skin.
Zhang ZJ; Michniak-Kohn B
Int J Pharm; 2020 Jul; 585():119500. PubMed ID: 32512226
[TBL] [Abstract][Full Text] [Related]
22. Non-steroidal anti-inflammatory drugs for acute gout.
van Durme CM; Wechalekar MD; Landewé RB; Pardo Pardo J; Cyril S; van der Heijde D; Buchbinder R
Cochrane Database Syst Rev; 2021 Dec; 12(12):CD010120. PubMed ID: 34882311
[TBL] [Abstract][Full Text] [Related]
23. Transdermal enhancement effect and mechanism of iontophoresis for non-steroidal anti-inflammatory drugs.
Zuo J; Du L; Li M; Liu B; Zhu W; Jin Y
Int J Pharm; 2014 May; 466(1-2):76-82. PubMed ID: 24607207
[TBL] [Abstract][Full Text] [Related]
24. Microemulsions as transdermal drug delivery systems for nonsteroidal anti-inflammatory drugs (NSAIDs): a literature review.
Benbow T; Campbell J
Drug Dev Ind Pharm; 2019 Dec; 45(12):1849-1855. PubMed ID: 31617433
[TBL] [Abstract][Full Text] [Related]
25. Microemulsion-Based Topical Hydrogels of Tenoxicam for Treatment of Arthritis.
Goindi S; Narula M; Kalra A
AAPS PharmSciTech; 2016 Jun; 17(3):597-606. PubMed ID: 26285672
[TBL] [Abstract][Full Text] [Related]
26. Construction of a quantitative structure-permeability relationship (QSPR) for the transdermal delivery of NSAIDs.
Liou YB; Ho HO; Yang CJ; Lin YK; Sheu MT
J Control Release; 2009 Sep; 138(3):260-7. PubMed ID: 19467276
[TBL] [Abstract][Full Text] [Related]
27. Nano-proniosomes enhancing the transdermal delivery of mefenamic acid.
Wen MM; Farid RM; Kassem AA
J Liposome Res; 2014 Dec; 24(4):280-9. PubMed ID: 24779560
[TBL] [Abstract][Full Text] [Related]
28. Preparation and characterization of microemulsion formulations of nicotinic acid and its prodrugs for transdermal delivery.
Tashtoush BM; Bennamani AN; Al-Taani BM
Pharm Dev Technol; 2013; 18(4):834-43. PubMed ID: 23030413
[TBL] [Abstract][Full Text] [Related]
29. Nanocrystals Technology for Transdermal Delivery of Water-Insoluble Drugs.
Liu Y; Zhao J; Wang L; Yan B; Gu Y; Chang P; Wang Y
Curr Drug Deliv; 2018; 15(9):1221-1229. PubMed ID: 29779482
[TBL] [Abstract][Full Text] [Related]
30. Development of matrix-type transdermal delivery of lornoxicam: in vitro evaluation and pharmacodynamic and pharmacokinetic studies in albino rats.
Baviskar DT; Parik VB; Jain DJ
PDA J Pharm Sci Technol; 2013; 67(1):9-22. PubMed ID: 23385560
[TBL] [Abstract][Full Text] [Related]
31. Preparation, evaluation, and NMR characterization of vinpocetine microemulsion for transdermal delivery.
Hua L; Weisan P; Jiayu L; Ying Z
Drug Dev Ind Pharm; 2004 Jul; 30(6):657-66. PubMed ID: 15285339
[TBL] [Abstract][Full Text] [Related]
32. A Study of Microemulsion Systems for Transdermal Delivery of Risperidone Using Penetration Enhancers.
Virani A; Dholaria N; Matharoo N; Michniak-Kohn B
J Pharm Sci; 2023 Dec; 112(12):3109-3119. PubMed ID: 37429357
[TBL] [Abstract][Full Text] [Related]
33. Enhanced transdermal permeability of piroxicam through novel nanoemulgel formulation.
Dhawan B; Aggarwal G; Harikumar S
Int J Pharm Investig; 2014 Apr; 4(2):65-76. PubMed ID: 25006551
[TBL] [Abstract][Full Text] [Related]
34. Effect of nanostructured lipid carriers on transdermal delivery of tenoxicam in irradiated rats.
Bawazeer S; El-Telbany DFA; Al-Sawahli MM; Zayed G; Keed AAA; Abdelaziz AE; Abdel-Naby DH
Drug Deliv; 2020 Dec; 27(1):1218-1230. PubMed ID: 32772730
[TBL] [Abstract][Full Text] [Related]
35. Enhancement strategies for transdermal drug delivery systems: current trends and applications.
Ramadon D; McCrudden MTC; Courtenay AJ; Donnelly RF
Drug Deliv Transl Res; 2022 Apr; 12(4):758-791. PubMed ID: 33474709
[TBL] [Abstract][Full Text] [Related]
36. Ionic Liquid-In-Oil Microemulsions Prepared with Biocompatible Choline Carboxylic Acids for Improving the Transdermal Delivery of a Sparingly Soluble Drug.
Islam MR; Chowdhury MR; Wakabayashi R; Kamiya N; Moniruzzaman M; Goto M
Pharmaceutics; 2020 Apr; 12(4):. PubMed ID: 32344768
[TBL] [Abstract][Full Text] [Related]
37. Testing Topical Products Specifically to Reduce Inflammatory Pain from Gout: Transdermal NSAID Delivery and Monosodium Urate Solubility.
Hooper MW; He L
J Pain Res; 2022; 15():1825-1835. PubMed ID: 35791391
[TBL] [Abstract][Full Text] [Related]
38. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
Aboofazeli R; Zia H; Needham TE
Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
[TBL] [Abstract][Full Text] [Related]
39. Oral non-steroidal anti-inflammatory drugs (single dose) for perineal pain in the early postpartum period.
Wuytack F; Smith V; Cleary BJ
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD011352. PubMed ID: 33427305
[TBL] [Abstract][Full Text] [Related]
40. Transdermal transport of collagen and hyaluronic acid using water in oil microemulsion.
Szumała P; Jungnickel C; Kozłowska-Tylingo K; Jacyna B; Cal K
Int J Pharm; 2019 Dec; 572():118738. PubMed ID: 31705977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
